F
Feng Shi
Researcher at Shanghai University
Publications - 11
Citations - 274
Feng Shi is an academic researcher from Shanghai University. The author has contributed to research in topics: Drug carrier & Supercritical fluid. The author has an hindex of 6, co-authored 11 publications receiving 242 citations.
Papers
More filters
Journal ArticleDOI
Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil
TL;DR: The presented SLNs can be used as drug carriers for hydrophobic oil drugs extracted from traditional Chinese medicines and increased the antitumor efficacy of FMO in H22-bearing Kunming mice.
Journal ArticleDOI
Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin.
TL;DR: The potential utility of WGA-grafted lipid nanoparticles for oral delivery of a poorly water-soluble drug such as bufalin is illustrated by its ex vivo bioadhesion with intestinal mucosal segments and in vivo bioavailability.
Journal ArticleDOI
Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers.
TL;DR: The data indicate that the α-E-NLCs described in this study are well-suited for the intravenous delivery of β-E, and showed a significantly higher bioavailability and anti-tumor efficacy than Elemene injection.
Journal ArticleDOI
Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion.
Yongtai Zhang,Jihui Zhao,Su-Juan Zhang,Yang-Zi Zhong,Zhi Wang,Ying Liu,Feng Shi,Nianping Feng +7 more
TL;DR: Compared to conventional formulations, higher cutaneous fluxes of evodiamine and rutaecarpine were achieved with microemulsion and the transdermal route was effective for the administration of the two active alkaloids.
Journal ArticleDOI
Preparation of a micro/nanotechnology based multi-unit drug delivery system for a Chinese medicine Niuhuang Xingxiao Wan and assessment of its antitumor efficacy.
TL;DR: Results reveal the feasibility of applying micro/nanotechnologies in formulating Chinese medicines and enhance the bioavailability and efficacy of a multi-unit drug delivery system for a Chinese medicine.